(Q37407598)

20 August 2017

1 reference

title

The challenge of finding a cure for HIV infection (English)

1 reference

20 August 2017

0 references

2

1 reference

20 August 2017

6

Roger J Pomerantz

1 reference

20 August 2017

Douglas D Richman

1

1 reference

20 August 2017

Martin Delaney

series ordinal

3

1 reference

20 August 2017

Warner C Greene

series ordinal

4

1 reference

20 August 2017

Daria Hazuda

series ordinal

5

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

323

1 reference

20 August 2017

issue

5919

1 reference

20 August 2017

page(s)

1304-1307

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

The survival benefits of AIDS treatment in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Prevalence and predictive value of intermittent viremia with combination hiv therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Cardiovascular risks of antiretroviral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Regulation of HIV-1 latency by T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Controlling the elongation phase of transcription with P-TEFb

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Molecular mechanisms of HIV-1 proviral latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Prostratin antagonizes HIV latency by activating NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Experimental approaches to the study of HIV-1 latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1165706

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.1165706

1 reference

release_vr27zmvsujgjnb7oxry4lo24ca

20 August 2017

0 references

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vr27zmvsujgjnb7oxry4lo24ca

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference